Anaphylaxis to dexrazoxane (ICRF-187) following three previous uncomplicated infusions

Allergy. 2004 Feb;59(2):241. doi: 10.1046/j.1398-9995.2003.00383.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anaphylaxis / chemically induced*
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Breast Neoplasms / drug therapy
  • Female
  • Humans
  • Infusions, Intravenous
  • Razoxane / administration & dosage
  • Razoxane / adverse effects*

Substances

  • Antineoplastic Agents
  • Razoxane